NCT06350032 Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH Status RECRUITING Phase PHASE3
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension Status AVAILABLE Phase N/A
NCT06317805 Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients Status RECRUITING Phase PHASE4
NCT06312111 Physical Activity and Various Aspects of Quality of Life in Patients With Pulmonary Arterial Hypertension (Ph-PAH) Status COMPLETED Phase NA
NCT06274801 Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) Status RECRUITING Phase PHASE3
NCT06196801 Efficacy of Triple-Combination Therapy in Severe PAH-CHD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06180096 Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets Status COMPLETED Phase PHASE1
NCT06176118 Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension Status NOT_YET_RECRUITING Phase PHASE2
NCT06137742 A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE1/PHASE2
NCT06104228 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) Status RECRUITING Phase PHASE2
NCT06092424 High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA) Status ACTIVE_NOT_RECRUITING Phase NA
NCT06072937 IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy Status NOT_YET_RECRUITING Phase NA
NCT06053580 Repurposing Valsartan May Protect Against Pulmonary Hypertension Status RECRUITING Phase PHASE2
NCT05977933 Assessing the Utility of Submaximal CPET in Treatment Management of PAH Status NOT_YET_RECRUITING Phase N/A
NCT05975905 A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). Status TERMINATED Phase PHASE2
NCT05968859 A Study of Pulmonary Hypertension Peripheral Limitations Status ACTIVE_NOT_RECRUITING Phase NA
NCT05948644 The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE1
NCT05947032 Supervised Endurance Training Among Pulmonary Arterial Hypertension Patients Status COMPLETED Phase NA